These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 25014023)

  • 61. Therapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse Model.
    Jiang W; Wei W; Gaertig MA; Li S; Li XJ
    PLoS One; 2015; 10(7):e0134142. PubMed ID: 26225560
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Transgenic animal models for study of the pathogenesis of Huntington's disease and therapy.
    Chang R; Liu X; Li S; Li XJ
    Drug Des Devel Ther; 2015; 9():2179-88. PubMed ID: 25931812
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington's disease.
    El-Akabawy G; Rattray I; Johansson SM; Gale R; Bates G; Modo M
    BMC Neurosci; 2012 Aug; 13():97. PubMed ID: 22876937
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin.
    Jin J; Cheng Y; Zhang Y; Wood W; Peng Q; Hutchison E; Mattson MP; Becker KG; Duan W
    J Neurochem; 2012 Nov; 123(4):477-90. PubMed ID: 22906125
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington's disease models.
    Sontag EM; Lotz GP; Agrawal N; Tran A; Aron R; Yang G; Necula M; Lau A; Finkbeiner S; Glabe C; Marsh JL; Muchowski PJ; Thompson LM
    J Neurosci; 2012 Aug; 32(32):11109-19. PubMed ID: 22875942
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lipoic acid improves survival in transgenic mouse models of Huntington's disease.
    Andreassen OA; Ferrante RJ; Dedeoglu A; Beal MF
    Neuroreport; 2001 Oct; 12(15):3371-3. PubMed ID: 11711888
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice.
    Jia H; Wang Y; Morris CD; Jacques V; Gottesfeld JM; Rusche JR; Thomas EA
    PLoS One; 2016; 11(3):e0152498. PubMed ID: 27031333
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease.
    Ruskin DN; Ross JL; Kawamura M; Ruiz TL; Geiger JD; Masino SA
    Physiol Behav; 2011 Jul; 103(5):501-7. PubMed ID: 21501628
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG
    Stefanko DP; Shah VD; Yamasaki WK; Petzinger GM; Jakowec MW
    Neurobiol Dis; 2017 Sep; 105():15-32. PubMed ID: 28502806
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease.
    Andreassen OA; Dedeoglu A; Ferrante RJ; Jenkins BG; Ferrante KL; Thomas M; Friedlich A; Browne SE; Schilling G; Borchelt DR; Hersch SM; Ross CA; Beal MF
    Neurobiol Dis; 2001 Jun; 8(3):479-91. PubMed ID: 11447996
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.
    Chiu FL; Lin JT; Chuang CY; Chien T; Chen CM; Chen KH; Hsiao HY; Lin YS; Chern Y; Kuo HC
    Hum Mol Genet; 2015 Nov; 24(21):6066-79. PubMed ID: 26264576
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington's Disease.
    Jang M; Lee SE; Cho IH
    Front Cell Neurosci; 2018; 12():157. PubMed ID: 29946240
    [TBL] [Abstract][Full Text] [Related]  

  • 73. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.
    Faideau M; Kim J; Cormier K; Gilmore R; Welch M; Auregan G; Dufour N; Guillermier M; Brouillet E; Hantraye P; Déglon N; Ferrante RJ; Bonvento G
    Hum Mol Genet; 2010 Aug; 19(15):3053-67. PubMed ID: 20494921
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Paroxetine retards disease onset and progression in Huntingtin mutant mice.
    Duan W; Guo Z; Jiang H; Ladenheim B; Xu X; Cadet JL; Mattson MP
    Ann Neurol; 2004 Apr; 55(4):590-4. PubMed ID: 15048901
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.
    Gu X; Greiner ER; Mishra R; Kodali R; Osmand A; Finkbeiner S; Steffan JS; Thompson LM; Wetzel R; Yang XW
    Neuron; 2009 Dec; 64(6):828-40. PubMed ID: 20064390
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Animal models of Huntington's disease: from basic research on neuronal death to assessment of new therapeutic strategies.
    Brouillet E
    Funct Neurol; 2000; 15(4):239-51. PubMed ID: 11213527
    [No Abstract]   [Full Text] [Related]  

  • 77. Ethological endophenotypes are altered by elevated stress hormone levels in both Huntington's disease and wildtype mice.
    Mo C; Renoir T; Hannan AJ
    Behav Brain Res; 2014 Nov; 274():118-27. PubMed ID: 25101541
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lack of minocycline efficiency in genetic models of Huntington's disease.
    Mievis S; Levivier M; Communi D; Vassart G; Brotchi J; Ledent C; Blum D
    Neuromolecular Med; 2007; 9(1):47-54. PubMed ID: 17114824
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Selenium Nanoparticles as an Efficient Nanomedicine for the Therapy of Huntington's Disease.
    Cong W; Bai R; Li YF; Wang L; Chen C
    ACS Appl Mater Interfaces; 2019 Sep; 11(38):34725-34735. PubMed ID: 31479233
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mutant huntingtin gene-dose impacts on aggregate deposition, DARPP32 expression and neuroinflammation in HdhQ150 mice.
    Young D; Mayer F; Vidotto N; Schweizer T; Berth R; Abramowski D; Shimshek DR; van der Putten PH; Schmid P
    PLoS One; 2013; 8(9):e75108. PubMed ID: 24086450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.